Z51.12 – Encounter for antineoplastic immunotherapy
ICD-10-CM 2027 diagnosis code · Encounters for other specific health care
ICD-10-CM code
Z51.12
- Code
Z51.12(claims format:Z5112)- Description
- Encounter for antineoplastic immunotherapy
- Billable
- Yes – valid for HIPAA-covered transactions
- Valid for
- Dates of service October 1, 2026 – September 30, 2027 (FY2027)
- Chapter
- 21. Factors influencing health status and contact with health services (Z00-Z99)
- Block
- Z40-Z53 Encounters for other specific health care
- Parent codes
- Z51 › Z51.1
Notes inherited from parent codes
Instructional notes at a category or block level apply to every code below it.
Z51 – Encounter for other aftercare and medical care
Code also:
- condition requiring care
Z51.1 – Encounter for antineoplastic chemotherapy and immunotherapy
Excludes2 (not included here):
- encounter for chemotherapy and immunotherapy for nonneoplastic condition - code to condition
Block Z40-Z53
Applicable to:
Index terms for Z51.12
Entries in the ICD-10-CM alphabetic index that lead to this code:
Related codes in Z51.1
Frequently asked questions
What is ICD-10 code Z51.12?
Z51.12 is the ICD-10-CM code for encounter for antineoplastic immunotherapy, in the block Z40-Z53 (Encounters for other specific health care).
Is Z51.12 a billable code?
Yes. Z51.12 is a billable/specific code that can be used to indicate a diagnosis for reimbursement purposes.
What category does Z51.12 belong to?
It belongs to category Z51 – Encounter for other aftercare and medical care.
Source: CDC/NCHS ICD-10-CM FY2027 code files, tabular list and index. Reference only – code assignment must follow the official ICD-10-CM guidelines and documentation in the medical record.